Articles

Can neuromodulation prevent the onset of metabolic dysfunction associated with the onset of diabetes?

What is a SGLT2 Inhibitor? Sodium-glucose co-transporter 2 (SGLT2) inhibitors, also called gliflozin drugs,  are a new class of diabetic medications indicated for the treatment of type 2 diabetes. They have also been found to show cardiac benefits in patients with diabetes, and are being studied for possible use in type 1 diabetes. They work by reducing the absorption of glucose via the kidneys so that excess glucose is excreted through urination.

Nonadherence to diabetes medications 2nd leading cause of hospitalizations

Two weeks of inactivity found to cause impaired glycemic control; may progress patients to type 2 diabetes

Newborns at increased risk for vascular complications, such as hypertension and cardiovascular disease.

A look into health conditions, other than diabetes, that may cause hypoglycemia.

Guest Post by David Kliff, Editor, Diabetic Investor

Whether the toy makers realize it or not, the key to getting their toys played with is to make the toy as easy to use as possible. This ease of use does not just mean things like easy insertion of a sensor, like Dexcom has done with the G6 or Abbott has done with the Libre. It goes beyond not having to calibrate either of these sensors. When it comes to increasing the use of insulin, it means making dosing insulin as “stupid” as possible; take all the decisions out of the hands of the patient.

Heart disease said cause of one on every four deaths in the U.S.

New study shows that nut intake may improve glycemic control and reduce risk of cardiovascular disease in people who have type 2 diabetes.

Study reveals men and woman with pre-diabetes respond differently to low energy diets and rapid weight loss.